ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
SARS-CoV-2 Main Protease: a Kinetic Approach
This article has 1 author:Reviewed by ScreenIT
-
Immunogenicity and safety of the CoronaVac inactivated SARS-CoV-2 vaccine in people with underlying medical conditions: a retrospective study
This article has 16 authors:Reviewed by ScreenIT
-
Keeping it close: The role of a Campus COVID Support Team (CCST) in sustaining a safe and healthy university campus during COVID-19
This article has 5 authors:Reviewed by ScreenIT
-
Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression
This article has 7 authors:Reviewed by ScreenIT
-
Outcomes of convalescent plasma with defined high- versus lower-neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus Inactivating Plasma (CoVIP), double-blind phase 2 study
This article has 21 authors:Reviewed by ScreenIT
-
Epidemiological and clinical features of SARS‐CoV‐2 infection in children during the outbreak of Omicron variant in Shanghai, March 7–31, 2022
This article has 14 authors:Reviewed by ScreenIT
-
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
This article has 96 authors:Reviewed by ScreenIT
-
Omicron infection induces low-level, narrow-range SARS-CoV-2 neutralizing activity
This article has 10 authors:Reviewed by ScreenIT
-
The highly conserved stem-loop II motif is important for the lifecycle of astroviruses but dispensable for SARS-CoV-2
This article has 17 authors:Reviewed by ScreenIT
-
Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals
This article has 5 authors:Reviewed by ScreenIT